Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy

• Asıl Yazarlar: Azin Dehghanimahmoudabadi, MD (Yazar), Nika Kianfar, MD, MPH (Yazar), Marwa Akhdar, MD (Yazar), Shayan Dasdar, MD, MPH (Yazar), Kamran Balighi, MD (Yazar), Hamidreza Mahmoudi, MD (Yazar), Maryam Daneshpazhooh, MD (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wolters Kluwer, 2022-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: . Rituximab (RTX) is an effective treatment for pemphigus; however, the drug labeling recommends not to use RTX within 1 year before conception. Objectives: . To report pregnancy outcomes of patients with pemphigus who were treated with RTX before or during pregnancy. Methods: . We ident...